ArticleRheumatology and therapy2021

Cost-effectiveness of Triple Therapy vs. Biologic Treatment Sequence as First-line Therapy for Rheumatoid Arthritis Patients after Methotrexate Failure.

SiNi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.